Risk Stratification of Nonmuscle Invasive Bladder Cancer and Innovative Approaches to Management of Ta Low-Grade Tumors

被引：1
|
作者：
Kim, Sung Han [1 ,2 ]
Lerner, Seth P. P. [2 ,3 ]
机构：
[1] Natl Canc Ctr, Res Inst & Hosp, Dept Urol, Goyang, South Korea
[2] Baylor Coll Med, Dan L Duncan Canc Ctr, Scott Dept Urol, Houston, TX USA
[3] Baylor Coll Med Med Ctr, Fac Affairs, Scott Dept Urol, Beth & Dave Swalm Chair Urol Oncol, 7200 Cambridge,MC BCM380, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 02期
关键词：
INTRAVESICAL MITOMYCIN-C; DIAGNOSIS; EFFICACY;
D O I：
10.1200/JCO.22.02104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：163 / +
页数：5
相关论文
共 50 条
  • [1] Therapy of low-grade nonmuscle-invasive bladder cancer
    Olbert, P. J.
    Ohlmann, C. H.
    Schwentner, C.
    UROLOGE, 2015, 54 (04): : 484 - 490
  • [2] Management, surveillance patterns, and costs associated with low-grade papillary (Ta) nonmuscle-invasive bladder cancer.
    Bree, Kelly K.
    Shan, Yong
    Hensley, Patrick J.
    Lobo, Niyati
    Hu, Chengrui
    Tyler, Douglas S.
    Chamie, Karim
    Kamat, Ashish M.
    Williams, Stephen B.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [3] Surveillance and office management of low-grade Ta bladder tumors
    Lokeshwar, S. D.
    Rahman, S. N.
    Press, B. H.
    Khan, A. I.
    Soloway, M. S.
    ACTAS UROLOGICAS ESPANOLAS, 2022, 46 (10): : 613 - 618
  • [4] A Case for Risk-adapted Management of Low-grade Bladder Tumors
    Soloway, Mark
    Matulay, Justin T.
    Kamat, Ashish M.
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (01): : 128 - 129
  • [5] Therapie des nicht-muskelinvasiven Low-grade-HarnblasenkarzinomsTherapy of low-grade nonmuscle-invasive bladder cancer
    P.J. Olbert
    C.H. Ohlmann
    C. Schwentner
    Der Urologe, 2015, 54 (4): : 484 - 490
  • [6] MANAGEMENT, SURVEILLANCE PATTERNS, AND COSTS ASSOCIATED WITH LOW-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER
    Bree, Kelly
    Shan, Yong
    Hensley, Patrick
    Lobo, Niyati
    Hu, Chengrui
    Tyler, Douglas
    Chamie, Karim
    Kamat, Ashish
    Williams, Stephen
    JOURNAL OF UROLOGY, 2022, 207 (05): : E669 - E669
  • [7] Managing Low-risk Nonmuscle Invasive Bladder Cancer
    Albertsen, Peter
    BJU INTERNATIONAL, 2022, 129 (06) : 659 - 660
  • [8] Management, surveillance patterns, and costs associated with low-grade Papillary (Ta) non-muscle invasive bladder cancer
    Bree, K. K.
    Shan, Y.
    Hensley, P. J.
    Lobo, N.
    Hu, C.
    Tyler, D. S.
    Chamie, K.
    Kamat, A. M.
    Williams, S. B.
    EUROPEAN UROLOGY, 2022, 81 : S236 - S236
  • [9] Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?
    Roupret, Morgan
    Malmstrom, Per-Uno
    Black, Peter
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (06): : 723 - 729
  • [10] Long-Term Recurrence Risk, Metastatic Potential, and Length of Cystoscopic Surveillance of Low-Grade Nonmuscle-Invasive Bladder Cancer
    Villegas, Eunice
    Lajkosz, Katherine
    Din, Shayan
    Kuk, Cynthia
    Chan, Amy
    Kwong, Jethro C. C.
    Vitug, Christian
    Gao, Bruce
    Hemminki, Otto
    Kot, Dhiral
    Misurka, Jimmy
    Black, Peter C.
    Jewett, Michael
    Soloway, Mark S.
    Roupret, Morgan
    Comperat, Eva
    Sweet, Joan
    Seisen, Thomas
    Fleshner, Neil E.
    Wrana, Jeffrey
    van der Kwast, Theodorus H.
    Kulkarni, Girish S.
    Zlotta, Alexandre R.
    JOURNAL OF UROLOGY, 2025, 213 (03): : 295 - 303
12345